Achintyan Gangadharan

Statistics

Publications

Citations

304

H-Index

Active since

2018

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Nationwide Children's Hospital

Achintyan Gangadharan is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, cancer immunotherapy, and immunology.

ORCID

Publications per year

2018–2024

Publications

IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses

Rosa M. Santana Carrero, Figen Beceren‐Braun, Sarai Rivas et al. · Proceedings of the National Academy of Sciences · 2018 · 130 citations · Full text

Medicine, Immunology, Oncology +17

Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma

Cavan P. Bailey, Mary Figueroa, Achintyan Gangadharan et al. · Neuro-Oncology · 2020 · 61 citations · Full text

Medicine, Cancer Biology, Pharmacology +16

Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity

Kay Hänggi, Jie Li, Achintyan Gangadharan et al. · Cancer Cell · 2024 · 56 citations · Full text

Life Sciences, Immunology, Oncology +14

Scaffolding LSD1 Inhibitors Impair NK Cell Metabolism and Cytotoxic Function Through Depletion of Glutathione

Cavan P. Bailey, Mary Figueroa, Achintyan Gangadharan et al. · Frontiers in Immunology · 2020 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

NKTR-255 is a polymer-conjugated IL-15 with unique mechanisms of action on T and natural killer cells

Tanya O. Robinson, Shweta Hegde, Allison Chang et al. · Journal of Clinical Investigation · 2021 · 22 citations · Full text

Life Sciences, Immunology, Oncology +11

1–5 of 5